Skip to Content

TE VA 7630 (Imatinib Mesylate 400 mg)

Pill with imprint TE VA 7630 is Brown, Capsule-shape and has been identified as Imatinib Mesylate 400 mg. It is supplied by Teva Pharmaceuticals USA, Inc..

Imatinib is used in the treatment of chronic myelogenous leukemia; gastrointestinal stromal tumor; chronic eosinophilic leukemia; myeloproliferative disorders; acute lymphoblastic leukemia (and more), and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Imatinib 400 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TE VA 7630

Imatinib mesylate 400 mg TE VA 7630

Imatinib Mesylate

Imprint:
TE VA 7630
Strength:
400 mg
Color:
Brown
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
BCR-ABL tyrosine kinase inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA, Inc.
National Drug Code (NDC):
00093-7630

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide